Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 63,245 shares at $224.18 ($14.3M) on 2025-02-04, disclosed to the SEC on 2025-02-06.
Scheduled sale ($14.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.00 | 9,099 | $2.0M | 14.2% |
| 2 | $224.18 | 1,519 | $341K | 2.4% |
| 3 | $224.18 | 1,519 | $341K | 2.4% |
| 4 | $225.27 | 2,161 | $487K | 3.4% |
| 5 | $225.27 | 2,161 | $487K | 3.4% |
| 6 | $226.35 | 17,805 |
| $4.0M |
| 28.2% |
| 7 | $226.35 | 17,805 | $4.0M | 28.2% |
| 8 | $227.00 | 9,776 | $2.2M | 15.5% |
| 9 | $228.04 | 1,400 | $319K | 2.2% |
| Total | $225.83 avg | 63,245 | $14.3M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |